TNFSF10 and cancer: Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL), a proinflammatory cytokine produced by our immune system, has shown promising success in controlling cancer threat, owing to its specific ability to induce apoptosis in cancers while having nominal effect on normal cells.7,8 Nevertheless, several malignant cancer types remain non-sensitive to TRAIL.